Frankfurt - Delayed Quote EUR
Onco-Innovations Limited (W1H.F)
0.9750
-0.0150
(-1.52%)
At close: June 10 at 8:40:53 PM GMT+2
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Thomas O'Shaughnessy | Chief Executive Officer | -- | -- | 1977 |
| Mr. Nico Mah | CFO & Corporate Secretary | -- | -- | 1996 |
| Dr. Fadia Saad M.B.A., Ph.D. | Consultant | -- | -- | 1964 |
| Dr. Frederick West | Technology Transfer Advisor | -- | -- | -- |
Onco-Innovations Limited
1309 - 7th Street SW
Calgary, AB T2R 1A5
Canada
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 1
Description
Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. Its lead product candidate is ONC010, a novel inhibitor of the deoxyribonucleic acid repair enzyme polynucleotide kinase 3'-phosphatase in a nanoparticle formulation based on the drug delivery technology. The company is headquartered in Calgary, Canada.
Corporate Governance
Onco-Innovations Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
HTD.SG Corcept Therapeutics Inc
62.88
+2.54%
9IP1.F Rocket Pharmaceuticals, Inc.
2.5000
+1.34%
UPB Upstream Bio, Inc.
11.59
+2.66%
DRMA Dermata Therapeutics, Inc.
0.7500
-1.03%
EWTX Edgewise Therapeutics, Inc.
15.45
+1.25%
SEPN Septerna, Inc.
10.28
+1.68%
SPRY ARS Pharmaceuticals, Inc.
14.69
+1.10%
MREO Mereo BioPharma Group plc
2.6500
0.00%
ELEV Elevation Oncology, Inc.
0.3827
-0.42%
CTMX CytomX Therapeutics, Inc.
2.7000
+2.47%